|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clark WH Jr, From L, Bernardino EA and
Mihm MC: The histogenesis and biologic behavior of primary human
malignant melanomas of the skin. Cancer Res. 29:705–727.
1969.PubMed/NCBI
|
|
3
|
Spatz A, Batist G and Eggermont AM: The
biology behind prognostic factors of cutaneous melanoma. Curr Opin
Oncol. 22:163–168. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lasithiotakis K, Leiter U, Meier F,
Eigentler T, Metzler G, Moehrle M, Breuninger H and Garbe C: Age
and gender are significant independent predictors of survival in
primary cutaneous melanoma. Cancer. 112:1795–1804. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Joosse A, De Vries E, van Eijck CH,
Eggermont AM, Nijsten T and Coebergh JW: Reactive oxygen species
and melanoma: An explanation for gender differences in survival?
Pigment Cell Melanoma Res. 23:352–364. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Joosse A, de Vries E, Eckel R, Nijsten T,
Eggermont AM, Hölzel D, Coebergh JW and Engel J: Munich Melanoma
Group: Gender differences in melanoma survival: Female patients
have a decreased risk of metastasis. J Invest Dermatol.
131:719–726. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Joosse A, Collette S, Suciu S, Nijsten T,
Lejeune F, Kleeberg UR, Coebergh JW, Eggermont AM and de Vries E:
Superior outcome of women with stage I/II cutaneous melanoma:
Pooled analysis of four European organisation for research and
treatment of cancer phase III trials. J Clin Oncol. 30:2240–2247.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Joosse A, Collette S, Suciu S, Nijsten T,
Patel PM, Keilholz U, Eggermont AM, Coebergh JW and de Vries E: Sex
is an independent prognostic indicator for survival and
relapse/progression-free survival in metastasized stage III to IV
melanoma: A pooled analysis of five European organisation for
research and treatment of cancer randomized controlled trials. J
Clin Oncol. 31:2337–2346. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Joosse A, van der Ploeg AP, Haydu LE,
Nijsten TE, de Vries E, Scolyer RA, Eggermont AM, Coebergh JW and
Thompson JF: Sex differences in melanoma survival are not related
to mitotic rate of the primary tumor. Ann Surg Oncol. 22:1598–1603.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mervic L, Leiter U, Meier F, Eigentler T,
Forschner A, Metzler G, Bartenjev I, Büttner P and Garbe C: Sex
differences in survival of cutaneous melanoma are age dependent: An
analysis of 7338 patients. Melanoma Res. 21:244–252. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
de Vries E, Nijsten TE, Visser O,
Bastiaannet E, van Hattem S, Janssen-Heijnen ML and Coebergh JW:
Superior survival of females among 10,538 Dutch melanoma patients
is independent of Breslow thickness, histologic type and tumor
site. Ann Oncol. 19:583–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Balch CM, Soong SJ, Gershenwald JE,
Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross
MI, Kirkwood JM, et al: Prognostic factors analysis of 17,600
melanoma patients: Validation of the American joint committee on
cancer melanoma staging system. J Clin Oncol. 19:3622–3634. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Scoggins CR, Ross MI, Reintgen DS, Noyes
RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Edwards
MJ, et al: Gender-related differences in outcome for melanoma
patients. Ann Surg. 243:693–698. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leiter U, Meier F, Schittek B and Garbe C:
The natural course of cutaneous melanoma. J Surg Oncol. 86:172–178.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu W, Dowling JP, Murray WK, McArthur GA,
Thompson JF, Wolfe R and Kelly JW: Rate of growth in melanomas:
Characteristics and associations of rapidly growing melanomas. Arch
Dermatol. 142:1551–1558. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Richard MA, Grob JJ, Avril MF, Delaunay M,
Thirion X, Wolkenstein P, Souteyrand P, Dreno B, Bonerandi JJ,
Dalac S, et al: Melanoma and tumor thickness: Challenges of early
diagnosis. Arch Dermatol. 135:269–274. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lens MB, Reiman T and Husain AF: Use of
tamoxifen in the treatment of malignant melanoma. Cancer.
98:1355–1361. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Molife R, Lorigan P and MacNeil S: Gender
and survival in malignant tumours. Cancer Treat Rev. 27:201–209.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jhaveri MB, Driscoll MS and Grant-Kels JM:
Melanoma in pregnancy. Clin Obstet Gynecol. 54:537–545. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Le Marchand L, Saltzman BS, Hankin JH,
Wilkens LR, Franke AA, Morris SJ and Kolonel LN: Sun exposure,
diet, and melanoma in Hawaii Caucasians. Am J Epidemiol.
164:232–245. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Long GV, Menzies AM, Nagrial AM, Haydu LE,
Hamilton AL, Mann GJ, Hughes TM, Thompson JF, Scolyer RA and
Kefford RF: Prognostic and clinicopathologic associations of
oncogenic BRAF in metastatic melanoma. J Clin Oncol. 29:1239–1246.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Devitt B, Liu W, Salemi R, Wolfe R, Kelly
J, Tzen CY, Dobrovic A and McArthur G: Clinical outcome and
pathological features associated with NRAS mutation in cutaneous
melanoma. Pigment Cell Melanoma Res. 24:666–672. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kong Y, Si L, Zhu Y, Xu X, Corless CL,
Flaherty KT, Li L, Li H, Sheng X, Cui C, et al: Large-scale
analysis of KIT aberrations in Chinese patients with melanoma. Clin
Cancer Res. 17:1684–1691. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thompson JF, Soong SJ, Balch CM,
Gershenwald JE, Ding S, Coit DG, Flaherty KT, Gimotty PA, Johnson
T, Johnson MM, et al: Prognostic significance of mitotic rate in
localized primary cutaneous melanoma: An analysis of patients in
the multi-institutional American joint committee on cancer melanoma
staging database. J Clin Oncol. 29:2199–2205. 2011. View Article : Google Scholar : PubMed/NCBI
|
